Protected Versus Early Weight Bearing Post Microfracture Surgery
Launched by ROBERT JONES AND AGNES HUNT ORTHOPAEDIC AND DISTRICT NHS TRUST · Sep 3, 2015
Trial Information
Current as of May 22, 2025
Terminated
Keywords
ClinConnect Summary
To test using a randomised control trial, whether conservative rehabilitation and protected weight bearing versus early weight bearing and accelerated rehabilitation affects patient outcomes post microfracture surgery of the knee.
Current practice in most units is to protect patients from weight bearing prior to entering a conservative physiotherapy rehabilitation program following microfracture surgery of the knee. At our unit we believe that protecting patients from weight bearing post microfracture surgery makes no difference to their outcome and only leads to a longer rehabilitation ti...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 16-60 years. Mechanically stable knee joint at outpatient examination. MRI confirmed grade 3 or 4 non-kissing cartilage defect within the knee. Able to fully understand the process and study and give informed consent to participate.
- • Able to comply with the physiotherapy rehabilitation and follow up process.
- Exclusion Criteria:
- • Kissing cartilage defects. Defects deemed too large to undergo microfracture on MRI scan. Clinically unstable knee joint. Patients unable to consent to participation. Under 16 years of age or over 60 years of age. Patients likely to drop out of physiotherapy rehabilitation and study follow up.
About Robert Jones And Agnes Hunt Orthopaedic And District Nhs Trust
The Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust is a leading healthcare provider in orthopaedic care, dedicated to delivering high-quality clinical services and advancing medical research. Located in Oswestry, England, the Trust specializes in the diagnosis, treatment, and rehabilitation of musculoskeletal conditions, with a strong emphasis on innovation and evidence-based practice. As a clinical trial sponsor, the Trust collaborates with healthcare professionals and researchers to facilitate cutting-edge studies aimed at improving patient outcomes and enhancing the understanding of orthopaedic disorders. Its commitment to patient safety, ethical standards, and scientific integrity makes it a trusted partner in the advancement of orthopaedic medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oswestry, Shropshire, United Kingdom
Patients applied
Trial Officials
Peter Gallacher, Surgeon
Study Director
NHS Healthcare
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials